Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib

AIM: To investigate in greater detail the efficacy and safety of sorafenib for the treatment of hepatocellular carcinoma (HCC) in patients with established cirrhosis. METHODS: From October 2009 to July 2012 patients with an established diagnosis of cirrhosis and HCC treated with sorafenib were conse...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Inghilesi, Andrea L, Gallori, Donatella, Antonuzzo, Lorenzo, Forte, Paolo, Tomcikova, Daniela, Arena, Umberto, Colagrande, Stefano, Pradella, Silvia, Fani, Bernardo, Gianni, Elena, Boni, Luca, Laffi, Giacomo, Costanzo, Francesco Di, Marra, Fabio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Co., Limited 2014
Konular:
Brief Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3921487/
https://ncbi.nlm.nih.gov/pubmed/24574751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i3.786
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller